These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Treatment of parkinsonism with L-dopa]. Court J; Kase JC; Palacios E; Mena I Rev Med Chil; 1971 Jun; 99(6):399-401. PubMed ID: 5561157 [No Abstract] [Full Text] [Related]
4. [Efficacy and side effects of L-dopa in patients with Parkinson's syndrome]. Lombardo L Arch Invest Med (Mex); 1973; 4(3):215-24. PubMed ID: 4784173 [No Abstract] [Full Text] [Related]
5. [Clinical experience with L-DOPA in the treatment of parkinsonism]. Chiba T No To Shinkei; 1970 Dec; 22(12):1399-405. PubMed ID: 5536833 [No Abstract] [Full Text] [Related]
6. [Clinical effect of L-DOPA and electromyographic study of Parkinsonism]. Sato G; Ito H; Handa Y; Takahashi I; Iijima K No To Shinkei; 1971 Mar; 23(3):325-32. PubMed ID: 5107821 [No Abstract] [Full Text] [Related]
7. Slowly absorbed L-dopa preparation in the treatment of parkinsonism. Laitinen LV Acta Neurol Scand; 1973; 49(3):331-8. PubMed ID: 4747020 [No Abstract] [Full Text] [Related]
8. [Long term treatment of a parkinsonism with l-dopa]. Presthus J Tidsskr Nor Laegeforen; 1973 Oct; 93(28):2111-3. PubMed ID: 4590069 [No Abstract] [Full Text] [Related]
9. L-Dopa (L-3,4-dihydroxyphenylanine)--its clinical effects in parkinsonism. Yahr MD; Duvoisin RC; Hoehn MM; Schear MJ; Barrett RE Trans Am Neurol Assoc; 1968; 93():56-63. PubMed ID: 4885744 [No Abstract] [Full Text] [Related]
10. [Potentiation of L-Dopa in parkinsonism by means of an inhibitor of peripheral decarboxylation]. Court J; Kase JC; Mena I; Palacios E Rev Med Chil; 1973 Jun; 101(6):452-5. PubMed ID: 4764560 [No Abstract] [Full Text] [Related]
11. Treatment of severe parkinsonism with L-dopa. Reef HE; Joffe R; Milletz H S Afr Med J; 1971 May; 45(18):504-7. PubMed ID: 4941208 [No Abstract] [Full Text] [Related]
12. Injected apomorphine and orally administered levodopa in Parkinsonism. Düby SE; Cotzias GC; Papavasiliou PS; Lawrence WH Arch Neurol; 1972 Dec; 27(6):474-80. PubMed ID: 4563448 [No Abstract] [Full Text] [Related]
13. [Treatment of parkinsonism with L-dopa]. Latuf NL; Colbachini MJ; Galvão JA Arq Neuropsiquiatr; 1972 Jun; 30(2):138-43. PubMed ID: 5045943 [No Abstract] [Full Text] [Related]
14. Long-term treatment of Parkinsonism with L-dopa. Presthus J; Holmsen R Acta Neurol Scand Suppl; 1972; 51():131-2. PubMed ID: 4514340 [No Abstract] [Full Text] [Related]
15. L-dopa in the treatment of Parkinsonism. Brezný I; Buranová D; Cernácek J; Trávniková M Act Nerv Super (Praha); 1972; 14(2):96. PubMed ID: 5040182 [No Abstract] [Full Text] [Related]
16. Combined L-dopa and amantadine in Parkinsonism. Pollock M; Jorgensen PB Aust N Z J Med; 1972 Aug; 2(3):252-5. PubMed ID: 4564049 [No Abstract] [Full Text] [Related]
17. L-dopa in the treatment of Parkinsonism; a preliminary appraisal. Stellar S; Mandell S; Waltz JM; Cooper IS J Neurosurg; 1970 Mar; 32(3):275-80. PubMed ID: 5416909 [No Abstract] [Full Text] [Related]
18. Mood changes during l-dopa therapy. Anumonye A J Med Soc N J; 1972 Feb; 69(2):139-43. PubMed ID: 4550284 [No Abstract] [Full Text] [Related]
19. [Current treatment of Parkinson syndrome with L-dopa]. Gerstendbrand F; Gründig E; Musiol A Pol Tyg Lek; 1972 May; 27(21):798-800. PubMed ID: 4555002 [No Abstract] [Full Text] [Related]
20. L-DOPA in Parkinson's disease. Results of a co-operative study in the Montreal area. Mars H; Libman I; Schwartz AM; Gillo-Joffroy L; Barbeau A Can Psychiatr Assoc J; 1972 Apr; 17(2):123-31. PubMed ID: 5036506 [No Abstract] [Full Text] [Related] [Next] [New Search]